Cargando…

Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses

T cells expressing high levels of inhibitory receptors such as PD-1 and LAG-3 are a hallmark of chronic infections and cancer. Checkpoint blockade therapies targeting these receptors have been largely validated as promising strategies to restore exhausted T cell functions and clearance of chronic in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furtado, Raquel, Chorro, Laurent, Zimmerman, Natalie, Guillen, Erik, Spaulding, Emily, Chin, Shu Shien, Daily, Johanna P., Lauvau, Grégoire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840658/ https://www.ncbi.nlm.nih.gov/pubmed/33519801 http://dx.doi.org/10.3389/fimmu.2020.576743

Ejemplares similares

STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria
por: Spaulding, Emily, et al.
Publicado: (2016)

T cell receptor and IL-2 signaling strength control memory CD8(+) T cell functional fitness via chromatin remodeling
por: Chin, Shu Shien, et al.
Publicado: (2022)

Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape
por: Chorro, Laurent, et al.
Publicado: (2018)

PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy
por: Zahm, Christopher D., et al.
Publicado: (2021)

The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade
por: Andrews, Lawrence P, et al.
Publicado: (2015)

PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma
por: Tobin, Joshua W. D., et al.
Publicado: (2021)

Therapeutic PD-L1 and LAG-3 blockade rapidly clears established blood-stage Plasmodium infection
por: Butler, Noah S., et al.
Publicado: (2011)

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3
por: Marcq, Elly, et al.
Publicado: (2021)

The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
por: Kreidieh, Firas Y., et al.
Publicado: (2023)

PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury
por: Triantafyllou, Evangelos, et al.
Publicado: (2021)

Blockade of PD-1 and LAG-3 expression on CD8+ T cells promotes the tumoricidal effects of CD8+ T cells
por: Ma, Jiajia, et al.
Publicado: (2023)

PI3-kinase, the key for bugs to get in?
por: Lauvau, Grégoire
Publicado: (2015)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4(+) T Cells
por: Saleh, Reem, et al.
Publicado: (2019)

Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
por: Huang, Ruea-Yea, et al.
Publicado: (2016)

CD169(+) macrophages orchestrate plasmacytoid dendritic cell arrest and retention for optimal priming in the bone marrow of malaria-infected mice
por: Moore-Fried, Jamie, et al.
Publicado: (2022)

Prenatal vitamin D deficiency alters immune cell proportions of young adult offspring through alteration of long-term stem cell fates
por: Ueda, Koki, et al.
Publicado: (2023)

Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint Blockade
por: Niu, Bailin, et al.
Publicado: (2019)

Malaria parasite clearance
por: White, Nicholas J.
Publicado: (2017)

Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
por: Lin, Yan, et al.
Publicado: (2020)

Cytolytic circumsporozoite-specific memory CD4(+) T cell clones are expanded during Plasmodium falciparum infection
por: Furtado, Raquel, et al.
Publicado: (2023)

Memory CD8(+) T Cells: Orchestrators and Key Players of Innate Immunity?
por: Lauvau, Grégoire, et al.
Publicado: (2016)

Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
por: Hu, Yun, et al.
Publicado: (2022)

Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
por: Baruch, Kuti, et al.
Publicado: (2020)

Shedding Light on the Role of the Skin in Vaccine-Induced Protection against the Malaria Sporozoite
por: Daily, Johanna Patricia
Publicado: (2018)

Cd8 T Cell Detection of Bacterial Infection: Sniffing for Formyl Peptides Derived from Mycobacterium tuberculosis
por: Lauvau, Gregoire, et al.
Publicado: (2001)

Erratum to: Malaria parasite clearance
por: White, Nicholas J.
Publicado: (2017)

LAG3-PD-1 Combo Overcome the Disadvantage of Drug Resistance
por: Wei, Yiming, et al.
Publicado: (2022)

Response: Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
por: Lin, Yan, et al.
Publicado: (2020)

POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval
por: Bikhchandani, Mihir, et al.
Publicado: (2023)

Ultrasound to the Rescue: Axillary Clearance under Complete Regional Blockade
por: Munasinghe, B. M, et al.
Publicado: (2021)

ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunity
por: Kozlovski, Stav, et al.
Publicado: (2023)

Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator
por: Flegg, Jennifer A, et al.
Publicado: (2011)

The influence of neuromuscular blockade on phase lag entropy and bispectral index: A randomized, controlled trial
por: Jin, Sohee, et al.
Publicado: (2021)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

974. PD-1 Immune Checkpoint Blockade Improves Survival and Promotes Fungal Clearance in an Immunosuppressed Murine Invasive Pulmonary Aspergillosis (IPA) Model
por: Wurster, Sebastian, et al.
Publicado: (2019)

An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade
por: Zuo, Shuguang, et al.
Publicado: (2021)

Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more
por: Turnis, Meghan E., et al.
Publicado: (2012)

Seasonally lagged effects of climatic factors on malaria incidence in South Africa
por: Ikeda, Takayoshi, et al.
Publicado: (2017)

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures
por: Gestermann, Nicolas, et al.
Publicado: (2020)

Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies
por: Gide, Tuba N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_54tbsvn0chqrcvss7m2b5qqnht